Cargando…
Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exacerbation requiring hospitalization: a disease risk score-matched nested case–control study
BACKGROUND: Exacerbation of chronic obstructive pulmonary disease (COPD) severely impacts the quality of life and causes high mortality and morbidity. COPD is involved with systemic and pulmonary inflammation, which may be attenuated with antidiabetic agents exerting anti-inflammatory effects. Real-...
Autores principales: | Wang, Meng-Ting, Lai, Jyun-Heng, Huang, Ya-Ling, Kuo, Feng-Chih, Wang, Yun-Han, Tsai, Chen-Liang, Tu, Min-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709288/ https://www.ncbi.nlm.nih.gov/pubmed/33267895 http://dx.doi.org/10.1186/s12931-020-01547-1 |
Ejemplares similares
-
Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease
por: Wang, Meng-Ting, et al.
Publicado: (2019) -
Serum bilirubin and the risk of chronic obstructive pulmonary disease exacerbations
por: Brown, Kirstin E., et al.
Publicado: (2017) -
Frailty in Chronic Obstructive Pulmonary Disease and Risk of Exacerbations and Hospitalizations
por: Yee, Nathan, et al.
Publicado: (2020) -
Association between use of oral-antidiabetic drugs and the risk of aortic aneurysm: a nested case–control analysis
por: Hsu, Chien-Yi, et al.
Publicado: (2016) -
Virus infection in exacerbations of chronic obstructive pulmonary disease
requiring ventilation
por: Cameron, Robert J., et al.
Publicado: (2006)